1. Auger C, Alhasawi A, Contavadoo M, et al. Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders. Front Cell Dev Biol. 2015 Jun 25;3:40.

2. Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology. 2004 May 20;198(1-3):147-59.

3. Nagini S, Palitti F, Natarajan AT. Chemopreventive potential of chlorophyllin: A review of the mechanisms of action and molecular targets.Nutr Cancer. 2015;67(2):203-11.

4. Gouda EM, Elbehairy AM, Ghoneim MA. Antimutagenic efficacy of some natural compounds on cyclophosphamide-induced p53 alterations. Z Naturforsch C. 2008 Nov-Dec;63(11-12):857-63.

5. Hayatsu H. Complex formation of heterocyclic amines with porphyrins: its use in detection and prevention.Princess Takamatsu Symp. 1995;23:172-80.

7. John K, Keshava C, Richardson DL, et al. Immune Response Signatures of Benzo(α)pyrene Exposure in Normal Human Mammary Epithelial Cells in the Absence or Presence of Chlorophyllin. Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):1-11.

8. John K, Divi RL, Keshava C, et al. CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllin. Cancer Lett. 2010 Jun 28;292(2):254-60.

9. Mata JE, Yu Z, Gray JE, et al. Effects of chlorophyllin on transport ofdibenzo(a, l)pyrene, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine,and aflatoxin B(1) across Caco-2 cell monolayers. Toxicology. 2004 Mar1;196(1-2):117-25.

10. Vidya Priyadarsini R, Kumar N, Khan I, et al. Gene expression signature of DMBA-induced hamster buccal pouch carcinomas: modulation by chlorophyllin and ellagic acid. PLoS One. 2012;7(4):e34628.

11. Konickova R, Vankova K, Vanikova J, et al. Anti-cancer effects of bluegreen alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds. Ann Hepatol. 2014 Mar-Apr;13(2):273-83.

12. Chimploy K, Diaz GD, Li Q, et al. E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin. International journal of cancer. Int J Cancer. 2009 Nov 1;125(9):2086-94.

13. Lihuan D, Jingcun Z, Ning J, et al. Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells. Lasers Surg Med. 2014 Apr;46(4):319-34.

14. Thiyagarajan P, Kavitha K, Thautam A, et al. Dietary chlorophyllin abrogates TGF-beta signaling to modulate the hallmark capabilities of cancer in an animal model of forestomach carcinogenesis. Tumour Biol. 2014 Jul;35(7):6725-37.

15. Jubert C, Mata J, Bench G, et al. Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers. Cancer Prev Res (Phila). 2009 Dec;2(12):1015-22.

16. Egner PA, Wang JB, Zhu YR, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14601-6.

17. Kamat JP, Boloor KK, Devasagayam TP. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta. 2000 Sep 27;1487(2-3):113-27.

18. Boloor KK, Kamat JP, Devasagayam TP. Chlorophyllin as a protector of mitochondrial membranes against gamma-radiation and photosensitization. Toxicology. 2000 Nov 30;155(1-3):63-71.

19. Smith RJ. Nutrition and metabolism in hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2013 Apr;2(2):89-96.

20. Imai K, Aimoto T, Sato M, et al. Effects of sodium metallochlorophyllins on the activity and components of the microsomal drug-metabolizing enzyme system in rat liver[J]. Chemical & Pharmaceutical Bulletin, 1986, 34(10):4287-93.

21. Simonich M T, Mcquistan T, Jubert C, et al. Natural chlorophyll inhibits dibenzo[a,l]pyrene-induced liver and stomach carcinogenesis in rainbow trout[J]. Cancer Research, 2006, 66.

22. Lutz F, Frimmer M. Light amplified inhibition of oxidative phosphorylation by chlorophyllins in rat liver mitochondria.[J]. Zeitschrift Für Naturforschung.teil B.anorganische Chemie Organische Chemie Biochemie Biophysik Biologie, 1970, 25(5):514-516.

23. Harttig U, Bailey G S. Chemoprotection by natural chlorophylls in vivo: inhibition of dibenzo[a,l]pyrene-DNA adducts in rainbow trout liver.[J]. Carcinogenesis, 1998, 19(7):1323-1326.

24. Wolfrum C, Spener F. Chlorophyll-derived fatty acids regulate expression of lipid metabolizing enzymes in liver, a nutritional opportunity[J]. OCL - Oleagineux Corps Gras Lipides, 2001, 8(1):39-44.

25. Sato M, Konagai K, Kimura R, et al. Effect of sodium copper chlorophyllin on lipid peroxidation. V. Effect on peroxidative damage of rat liver lysosomes.[J]. Chemical & Pharmaceutical Bulletin, 1983, 31(10):3665-70.

26. Imai K, Aimoto T, Sato M, et al. Effects of sodium metallochlorophyllins on the activity and components of the microsomal drug-metabolizing enzyme system in rat liver[J]. Chemical & Pharmaceutical Bulletin, 1986, 34(10):4287-93.

27. Sato M, Imai K, Kimura R, et al. Effect of sodium copper chlorophyllin on lipid peroxidation. VI. Effect of its administration on mitochondrial and microsomal lipid peroxidation in rat liver.[J]. Chemical & Pharmaceutical Bulletin, 1984, 32(2):716-22.

28. Ferruzzi M G, Failla M L, Schwartz S J. Sodium copper chlorophyllin: in vitro digestive stability and accumulation by Caco-2 human intestinal cells[J]. Journal of Agricultural & Food Chemistry, 2002, 50(7):2173.

29. 马维健, 张洋, 虞在洋,等. 水葫芦中叶绿素铜钠提取及其抗细胞氧化损伤作用研究[J]. 现代生物医学进展, 2016, 16(1):45-49.

30. 杨峰亮, 赵轶, 虞和永. 高效液相法测定复方叶绿素铜钠栓中SMZ、TMP的含量[J]. 中国药学杂志, 2007, 42(23):1831-1832.

31. 沈卫镝. 保肝抗胃溃疡药物叶绿素铜钠主要组成分铜紫红素-18及其配位体紫红素-18的制备及生物活性研究[M]. 第二军医大学, 1999.

32. 程林. 叶绿素铜钠盐的药理学研究(一)[J]. 养生月刊, 2014(5):477-478.

33. 沈卫镝, 姚建忠. 铜紫红素—18的合成及其保肝抗溃疡活性的初步研究[J]. 中国医药工业杂志, 2002, 33(7):339-341.

34. 魏克民, 王守军, 浦锦宝,等. 肝血宝(叶绿素铜钠盐)治疗白细胞减少症985例临床疗效分析[J]. 中国中医药科技, 2009, 16(1):64-65.

35. 黄自然, 罗全, 庞国漳. 蚕类制取叶绿素衍生物及其在医药上的应用[J]. 蚕桑通报, 1980(3).

36. 魏克民. 肝血宝治疗慢性迁延性肝炎120例[J]. 中国中医药科技, 1998(1).

37. 许德余. 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途:, CN 1078468 C[P]. 2002.

38. 董太新, 杨仁登. 叶绿素铜钠片治疗药源性粒细胞减少和肝功能异常的疗效观察[J]. 中国民康医学, 2009, 21(22):2805-2805.

39. 冯景胜, 韩绪祥. Drink for dispelling effects of liquor and protecting liver and its preparation method: CN, CN 100493390 C[P]. 2009.

40. 丁小文. 叶绿酸铜钠预防化学诱导大肠肿瘤的实验研究及对HT29肠癌细胞的体外抑制作用研究[D]. 浙江大学, 2003.

41. 赵堂富, 魏克民. 叶绿素铜盐治疗造血障碍性贫血的实验研究[J]. 浙江医学, 1989(4):193-195.

42. 巨君芳, 周平, 张如富,等. 叶绿素铜钠盐联合环孢菌素A对免疫介导再生障碍性贫血模型小鼠的实验研究[J]. 浙江临床医学, 2008, 10(10):1300-1302.

43. 任莉. 叶绿素铜钠调节免疫介导再生障碍性贫血模型小鼠骨髓间充质干细胞的研究[D]. 浙江中医药大学, 2012.

44. 任莉, 蒋慧芳. 叶绿素铜钠对免疫介导再生障碍性贫血小鼠骨髓间充质干细胞TGF-β_1表达的影响[J]. 中国中医药科技, 2012, 19(4):327-328.

45. 王守军, 魏克民. 叶绿素铜钠盐联合中药拆方对免疫介导再生障碍性贫血小鼠T淋巴细胞亚群的影响[J]. 中国中医药科技, 2013, 20(6):618-619.

46. 林庚庭, 魏克民, 梁卫青,等. 叶绿素铜钠盐对AA模型基因表达谱的实验研究[J]. 医学研究杂志, 2005, 34(3):18-20.

47. 王灵聪, 蔡斌, 楼益平,等. 叶绿素铜钠对免疫介导再生障碍性贫血小鼠骨髓间充质干细胞向成骨细胞的分化研究[J]. 医学研究杂志, 2011, 40(10):62-64.

48. 舒海民, 赵轶, 金绮. 复方叶绿素铜钠栓的研制及临床应用[J]. 中国现代应用药学, 2006, 23(2):167-168.

49. 罗庆锋. 叶绿素的研究进展及叶绿素铜钠的开发利用[J]. 生物质化学工程, 1995(1):32-33.